PRECLINICAL AND CLINICAL STUDIES OF EXYCOTE, A NOVEL TBI THERAPEUTIC FOR COMBAT CASUALTIES

$1,877,955FY2011Department of DefenseDOD

Tenax Therapeutics, Inc.

Investigators

View source on USAspending →